Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
The author(s) reported there is no funding associated with the work featured in this article.
Letter to the Editor
Symptomatic SARS-CoV2 infection associated with high mortality in AA amyloidosis
Rim Bourguibaa Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France;b National French Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Paris, France
https://orcid.org/0000-0002-7352-9074View further author information
https://orcid.org/0000-0002-7352-9074View further author information, Alexandre Terréa Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France;b National French Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Paris, Francehttps://orcid.org/0000-0002-8295-9068View further author information
https://orcid.org/0000-0002-8295-9068View further author information, Lea Saveya Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France;b National French Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Paris, Francehttps://orcid.org/0000-0002-1989-1304View further author information
https://orcid.org/0000-0002-1989-1304View further author information, , , , , , , , & Sophie Georgin-Laviallea Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France;b National French Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Paris, France;h Sorbonne University, Paris, FranceCorrespondence[email protected]
https://orcid.org/0000-0001-6668-8854View further author information
https://orcid.org/0000-0001-6668-8854View further author information show all![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})